The next decade of vaccines: societal and scientific challenges, The Lancet, vol.378, issue.9788, pp.378-348, 2011. ,
DOI : 10.1016/S0140-6736(11)60407-8
Vaccines and autoimmunity, Nature Reviews Rheumatology, vol.23, issue.11, pp.5-648, 2009. ,
DOI : 10.1038/nrrheum.2009.196
Infection, vaccines and other environmental triggers of autoimmunity, Autoimmunity, vol.18, issue.3, pp.235-280, 2005. ,
DOI : 10.1080/08916930500050277
Neuromuscular disorders associated with Hepatitis B vaccination, Journal of the Neurological Sciences, vol.292, issue.1-2, pp.1-4, 2010. ,
DOI : 10.1016/j.jns.2010.02.016
Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle, Brain, vol.124, issue.9, pp.1821-1831, 2001. ,
DOI : 10.1093/brain/124.9.1821
Aluminum Adjuvant Linked to Gulf War Illness Induces Motor Neuron Death in Mice, NeuroMolecular Medicine, vol.9, issue.1, pp.83-100, 2007. ,
DOI : 10.1385/NMM:9:1:83
Antibodies to Squalene in Gulf War Syndrome, Experimental and Molecular Pathology, vol.68, issue.1, pp.55-64, 2000. ,
DOI : 10.1006/exmp.1999.2295
AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland, PLoS ONE, vol.21, issue.3, p.33536, 2012. ,
DOI : 10.1371/journal.pone.0033536.t004
The immunobiology of aluminium adjuvants: how do they really work?, Trends in Immunology, vol.31, issue.3, pp.31-103, 2010. ,
DOI : 10.1016/j.it.2009.12.009
Towards an understanding of the adjuvant action of aluminium, Nature Reviews Immunology, vol.49, issue.4, pp.287-293, 2009. ,
DOI : 10.1038/nri2510
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization, Nature Immunology, vol.109, issue.8, pp.847-56, 2008. ,
DOI : 10.1016/0008-8749(88)90236-5
The Common Immunogenic Etiology of Chronic Fatigue Syndrome: From Infections to Vaccines via Adjuvants to the ASIA Syndrome, Infectious Disease Clinics of North America, vol.25, issue.4, pp.25-851, 2011. ,
DOI : 10.1016/j.idc.2011.07.012
???ASIA??? ??? Autoimmune/inflammatory syndrome induced by adjuvants, Journal of Autoimmunity, vol.36, issue.1, pp.4-8, 2011. ,
DOI : 10.1016/j.jaut.2010.07.003
Lessons from Macrophagic Myofasciitis: Towards Definition of a Vaccine Adjuvant-Related Syndrome, Rev Neurol, vol.159, issue.2, pp.162-164, 2003. ,
DOI : 10.1007/978-94-010-0167-0_16
Aluminum inclusion macrophagic myofasciitis: a recently identified condition, Immunology and Allergy Clinics of North America, vol.23, issue.4, pp.699-712, 2003. ,
DOI : 10.1016/S0889-8561(03)00095-X
Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study, BMJ, vol.320, issue.7246, pp.1363-1367, 2000. ,
DOI : 10.1136/bmj.320.7246.1363
Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration, Journal of Inorganic Biochemistry, vol.103, issue.11, pp.1555-1562, 2009. ,
DOI : 10.1016/j.jinorgbio.2009.05.019
Hypergammaglobulinemia by prolonged adjuvanticity in man disorders developed after augmentation mammoplasty, Jpn. Med. J, vol.2122, pp.9-14, 1964. ,
HUMAN ADJUVANT DISEASE, Southern Medical Journal, vol.88, pp.179-88, 1996. ,
DOI : 10.1097/00007611-199510001-00115
Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): Old truths and a new syndrome?, Journal of Autoimmunity, vol.36, issue.1, pp.1-3, 2011. ,
DOI : 10.1016/j.jaut.2010.10.004
???ASIA???: a new systemic autoimmune syndrome?, Lupus, vol.50, issue.7, pp.665-671, 2011. ,
DOI : 10.1177/0961203309345724
Foreword, Lupus, vol.21, issue.2, p.117, 2012. ,
DOI : 10.1177/0961203311431250
Where there!s smoke there!s fire: the silicone breast implant controversy continues to flicker: a new disease that needs to be defined, J. Rheumatol, issue.10, pp.30-2092, 2003. ,
Macrophagic myofasciitis: an emerging entity, The Lancet, vol.352, issue.9125, pp.352-347, 1998. ,
DOI : 10.1016/S0140-6736(98)02326-5
Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction, Journal of Inorganic Biochemistry, vol.103, issue.11, pp.1571-1578, 2009. ,
DOI : 10.1016/j.jinorgbio.2009.08.005
Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF), Journal of Inorganic Biochemistry, vol.105, issue.11, pp.1457-1463, 2011. ,
DOI : 10.1016/j.jinorgbio.2011.08.006
Chronic fatigue syndrome in patients with macrophagic myofasciitis, Arthritis & Rheumatism, vol.56, issue.2, pp.569-570, 2003. ,
DOI : 10.1002/art.10740
Central nervous system disease in patients with macrophagic myofasciitis, Brain, vol.124, pp.974-83, 2001. ,
Al(OH)3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background, Neuromuscular Disorders, vol.16, issue.5, pp.347-352, 2006. ,
DOI : 10.1016/j.nmd.2006.02.004
URL : https://hal.archives-ouvertes.fr/in2p3-00068499
The adjuvants aluminium hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells, J Immunol. J. Immunol, vol.180182, issue.81, pp.5402-5414, 2008. ,
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview, Journal of Interferon & Cytokine Research, vol.29, issue.6, pp.29-313, 2009. ,
DOI : 10.1089/jir.2008.0027
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755091
Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury, Arthritis & Rheumatism, vol.100, issue.1, pp.62-268, 2010. ,
DOI : 10.1002/art.27183
URL : https://hal.archives-ouvertes.fr/pasteur-01402283
Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2, J. Exp. Med, issue.7, pp.192-1075, 2000. ,
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions, Nature Neuroscience, vol.72, issue.12, pp.1544-53, 2007. ,
DOI : 10.1038/nn2015
Cytokine polymorphisms associated with carotid intima-media thickness in stroke patients, Stroke, issue.7, pp.371691-371697, 2006. ,
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis, J. Exp. Med, vol.19, issue.12, pp.2021649-58, 2005. ,
The MCP-1-2518 (A to G) single nucleotide polymorphism in Czech patients with pulmonary sarcoidosis: association with Löfgren's syndrome, Sarcoidosis Vasc. Diffuse Lung Dis, issue.1, pp.24-33, 2007. ,
Polymorphisms in chemokine and chemokine receptor genes and the development of coal workers' pneumoconiosis, Cytokine, vol.33, issue.3, pp.33-171, 2006. ,
DOI : 10.1016/j.cyto.2006.01.001
URL : https://hal.archives-ouvertes.fr/inserm-00127760
Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis, Arthritis & Rheumatism, vol.73, issue.6, pp.50-1842, 2004. ,
DOI : 10.1002/art.20266
Association of the MCP-1 -2518 A/G Polymorphism and No Association of Its Receptor CCR2 -64 V/I Polymorphism with Lupus Nephritis, The Journal of Rheumatology, vol.37, issue.4, pp.776-82, 2010. ,
DOI : 10.3899/jrheum.090681
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels, Proc. Natl. Acad. Sci. U S A, issue.21, pp.99-13795, 2002. ,
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1, Nature, vol.404, issue.6776, pp.404-407, 2000. ,
DOI : 10.1038/35006097
Normal ageing is associated with an increase in Th2 cells, MCP-1 (CCL1) and RANTES (CCL5), with differences in sCD40L and PDGF-AA between sexes, Clinical & Experimental Immunology, vol.81, issue.2, pp.186-93, 2012. ,
DOI : 10.1111/j.1365-2249.2012.04644.x
Deretic, V. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis, Immunity, issue.3, pp.27-505, 2007. ,
Aboukhamis, I.; Rihn, B.; Drug delivery by polymeric nanoparticles induces autophagy in macrophages International, J. Pharmaceutics, pp.422-495, 2012. ,
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis, Nat. Genet, issue.5, pp.39-596, 2007. ,
Aluminum as an adjuvant in Crohn???s disease induction, Lupus, vol.16, issue.2, pp.231-239 ,
DOI : 10.1016/j.jaut.2010.07.003
Nanosized particles injected into muscle slowly disseminate within phagocytes and accumulate in brain through MCP1-driven mechanism, Communication at the 63rd American Academy of Neurology Annual Meeting, pp.76-186, 2011. ,
Chemokines and neuromodulation, Journal of Neuroimmunology, vol.198, issue.1-2, pp.62-70, 2008. ,
DOI : 10.1016/j.jneuroim.2008.04.022
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE), Seminars in Immunology, vol.15, issue.1, pp.23-32, 2003. ,
DOI : 10.1016/S1044-5323(02)00125-2
Monocyte Chemoattractant Protein-1 Plays a Dominant Role in the Chronic Inflammation Observed in Alzheimer's Disease, Brain Pathology, vol.28, issue.3, pp.19-392, 2009. ,
DOI : 10.1111/j.1750-3639.2008.00188.x
Roles of MCP-1 in development of HIV-dementia, Frontiers in Bioscience, vol.Volume, issue.13, pp.3913-3921, 2008. ,
DOI : 10.2741/2979
The Chemokine CCL2 Protects Against Methylmercury Neurotoxicity, Toxicological Sciences, vol.125, issue.1, pp.209-227 ,
DOI : 10.1093/toxsci/kfr252
URL : https://hal.archives-ouvertes.fr/inserm-00630697
Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice, FASEB J, issue.7, pp.19-761, 2005. ,
Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses, Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses, pp.706-714, 2007. ,
DOI : 10.1016/j.neuroscience.2007.08.014
Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons, Journal of Neurochemistry, vol.142, issue.0, pp.254-263, 2008. ,
DOI : 10.1038/sj.emboj.7600893
CCL2 is a key mediator of microglia activation in neuropathic pain states, European Journal of Pain, vol.27, issue.14, pp.263-272, 2009. ,
DOI : 10.1016/j.ejpain.2008.04.017
Chemokines, neuronal???glial interactions, and central processing of neuropathic pain, Pharmacology & Therapeutics, vol.126, issue.1, pp.56-68, 2010. ,
DOI : 10.1016/j.pharmthera.2010.01.002
MCP-1 and IL-8 as Pain Biomarkers in Fibromyalgia: A Pilot Study, Pain Medicine, vol.12, issue.8, pp.1154-61, 2011. ,
DOI : 10.1111/j.1526-4637.2011.01179.x
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease, Neurobiology of Aging, vol.27, issue.12, pp.271763-271771, 2006. ,
DOI : 10.1016/j.neurobiolaging.2005.10.007